Seroprevalence and risk factors associated with hepatitis C: a cross-sectional study of persons who inject drugs in Puerto Rico, 2018
- PMID: 37072733
- PMCID: PMC10111640
- DOI: 10.1186/s12889-023-15341-3
Seroprevalence and risk factors associated with hepatitis C: a cross-sectional study of persons who inject drugs in Puerto Rico, 2018
Abstract
Background: People Who Inject Drugs (PWID) are at a higher risk of acquiring bloodborne infections. We aimed to estimate the seroprevalence of the Hepatitis C Virus (HCV) in PWID and identify correlates and risk factors using data from the Puerto Rico National HIV Behavioral Surveillance System, PWID cycle 5, conducted in 2018.
Methods: A total of 502 San Juan Metropolitan Statistical Area participants were recruited through the Respondent Driven Sampling method. Sociodemographic, health-related, and behavioral characteristics were assessed. Testing for HCV antibodies was completed after the face-to-face survey. Descriptive and logistic regression analyses were performed.
Results: Overall seroprevalence of HCV was 76.5% (95% CI: 70.8-81.4%). A significantly (p < 0.05) higher HCV seroprevalence was observed among PWID with the following characteristics: heterosexuals (78.5%), high school graduates (81.3%), tested for sexually transmitted infections (STI) in the past 12 months (86.1%), frequent speedball injection (79.4%), and knowing the HCV serostatus of the last sharing partner (95.4%). Adjusted logistic regression models showed that having completed high school and reported STI testing in the past 12 months were significantly associated with HCV infection (ORa = 2.23; 95% CI: 1.06-4.69; ORa = 2.14; 95% CI: 1.06-4.30, respectively).
Conclusions: We report a high seroprevalence of HCV infection in PWID. Social health disparities and potential missed opportunities validate the continuing call for local action for public health and prevention strategies.
Keywords: HCV; HIV; NHBS; PWID; Puerto Rico.
© 2023. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
References
-
- Centers for Disease Control and Prevention. HIV Among People Who Inject Drugs [Internet]. 2022 [cited 2022 Feb 15]. Available from: https://www.cdc.gov/hiv/group/hiv-idu.html
-
- Centers for Disease Control and Prevention. Hepatitis C Surveillance in the United States for 2019 [Internet]. 2021 [cited 2022 Feb 14]. Available from: https://www.cdc.gov/hepatitis/statistics/2019surveillance/HepC.htm
-
- World Health Organization. People who inject drugs [Internet]. 2021 [cited 2022 Feb 15]. Available from: https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/popul...
-
- United Nations Office on Drugs and Crime. World Drug Report 2020 [Internet]. 2020 [cited 2022 Feb 14]. Available from: https://wdr.unodc.org/wdr2020/index2020.html
-
- Gomez MA, Fernandez DM, Otero JF, Miranda S, Hunter R. The shape of the HIV/AIDS epidemic in Puerto Rico.Pan American journal of Public Health. 2000 Jun;7(6). - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
